NCT05456009

Brief Summary

Identification of exhaled breath pattern of human subjects

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 19, 2019

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

June 30, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 13, 2022

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

August 15, 2024

Status Verified

August 1, 2024

Enrollment Period

7 years

First QC Date

June 30, 2022

Last Update Submit

August 14, 2024

Conditions

Exhaled Breath Pattern After Medication Intake, in OSA Patients, or Other Pulmonary Diseases

Outcome Measures

Primary Outcomes (1)

  • Exhaled breath pattern

    mass spectrometric profile of exhaled breath pattern of human subjects

    baseline

Secondary Outcomes (7)

  • Chemical structure of exhaled breath molecules

    baseline

  • Body fluids

    baseline

  • Disease marker

    baseline

  • Distinguish between disease

    baseline

  • Health state

    baseline

  • +2 more secondary outcomes

Interventions

No interventionOTHER

No intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Population of human subjects with heart failure, dementia syndrome, parkinson disease, obstructive sleep apnea, chronic obstructive pulmonary disease, pneumonia, specific medication use.

You may qualify if:

  • \>= 18 years
  • Informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich

Zurich, Canton of Zurich, 8091, Switzerland

RECRUITING

Central Study Contacts

Malcolm Kohler, MD

CONTACT

+41442551111malcolm.kohler@usz.ch

Noriane Sievi, MSc

CONTACT

+41442559815noriane.sievi@usz.ch

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2022

First Posted

July 13, 2022

Study Start

February 19, 2019

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

August 15, 2024

Record last verified: 2024-08

Locations

CH(1)